Caris & Co Upgrades Eclipsys (ECLP) to Above Average
ECLP Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
Caris & Co upgrades Eclipsys (Nasdaq: ECLP) from Average to Above Average. Price target increased from $18 to $23.
To see more analyst ratings on ECLP Click Here.
Eclipsys Corporation operates as a healthcare information technology company in North America, the southeast Asia, and the Middle East.
To see more analyst ratings on ECLP Click Here.
Eclipsys Corporation operates as a healthcare information technology company in North America, the southeast Asia, and the Middle East.
You May Also Be Interested In
- UPDATE: Nomura Securities Upgrades Central European Distribution (CEDC) to Neutral; Strategic Alliance with Russian Standard
- Barclays Maintains an 'Equalweight' on Trina Solar (TSL); Waiting on Growth in Gross Margins and Stabilized Opex
- UBS Raises Price Target and EPS Estimate on LyondellBasell Industries (LYB); Use Dip As Buying Opportunity
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
